| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.21 | 0.002 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.099 | 0.003 |